76 related articles for article (PubMed ID: 21539534)
1. Disabled-2 modulates homotypic and heterotypic platelet interactions by binding to sulfatides.
Welsh JD; Charonko JJ; Salmanzadeh A; Drahos KE; Shafiee H; Stremler MA; Davalos RV; Capelluto DG; Vlachos PP; Finkielstein CV
Br J Haematol; 2011 Jul; 154(1):122-33. PubMed ID: 21539534
[TBL] [Abstract][Full Text] [Related]
2. Structure, sulfatide binding properties, and inhibition of platelet aggregation by a disabled-2 protein-derived peptide.
Xiao S; Charonko JJ; Fu X; Salmanzadeh A; Davalos RV; Vlachos PP; Finkielstein CV; Capelluto DG
J Biol Chem; 2012 Nov; 287(45):37691-702. PubMed ID: 22977233
[TBL] [Abstract][Full Text] [Related]
3. Sulfatides activate platelets through P-selectin and enhance platelet and platelet-leukocyte aggregation.
Merten M; Beythien C; Gutensohn K; Kühnl P; Meinertz T; Thiagarajan P
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):258-63. PubMed ID: 15528476
[TBL] [Abstract][Full Text] [Related]
4. Sulfatides partition disabled-2 in response to platelet activation.
Drahos KE; Welsh JD; Finkielstein CV; Capelluto DG
PLoS One; 2009 Nov; 4(11):e8007. PubMed ID: 19956625
[TBL] [Abstract][Full Text] [Related]
5. Lipid-mediated membrane binding properties of Disabled-2.
Alajlouni R; Drahos KE; Finkielstein CV; Capelluto DG
Biochim Biophys Acta; 2011 Nov; 1808(11):2734-44. PubMed ID: 21820403
[TBL] [Abstract][Full Text] [Related]
6. Role for sulfatides in platelet aggregation.
Merten M; Thiagarajan P
Circulation; 2001 Dec; 104(24):2955-60. PubMed ID: 11739312
[TBL] [Abstract][Full Text] [Related]
7. Structural, in silico, and functional analysis of a Disabled-2-derived peptide for recognition of sulfatides.
Song W; Gottschalk CJ; Tang TX; Biscardi A; Ellena JF; Finkielstein CV; Brown AM; Capelluto DGS
Sci Rep; 2020 Aug; 10(1):13520. PubMed ID: 32782308
[TBL] [Abstract][Full Text] [Related]
8. Disabled-2 is a novel alphaIIb-integrin-binding protein that negatively regulates platelet-fibrinogen interactions and platelet aggregation.
Huang CL; Cheng JC; Stern A; Hsieh JT; Liao CH; Tseng CP
J Cell Sci; 2006 Nov; 119(Pt 21):4420-30. PubMed ID: 17074833
[TBL] [Abstract][Full Text] [Related]
9. Preferential binding of platelets to monocytes over neutrophils under flow.
Ahn KC; Jun AJ; Pawar P; Jadhav S; Napier S; McCarty OJ; Konstantopoulos K
Biochem Biophys Res Commun; 2005 Apr; 329(1):345-55. PubMed ID: 15721313
[TBL] [Abstract][Full Text] [Related]
10. Principal role of glycoprotein VI in alpha2beta1 and alphaIIbbeta3 activation during collagen-induced thrombus formation.
Lecut C; Schoolmeester A; Kuijpers MJ; Broers JL; van Zandvoort MA; Vanhoorelbeke K; Deckmyn H; Jandrot-Perrus M; Heemskerk JW
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1727-33. PubMed ID: 15231520
[TBL] [Abstract][Full Text] [Related]
11. Involvement of activated integrin alpha2beta1 in the firm adhesion of platelets onto a surface of immobilized collagen under flow conditions.
Moroi M; Onitsuka I; Imaizumi T; Jung SM
Thromb Haemost; 2000 May; 83(5):769-76. PubMed ID: 10823276
[TBL] [Abstract][Full Text] [Related]
12. Effect of an anti-sulfatide single-chain antibody probe on platelet function.
Guchhait P; Shrimpton CN; Honke K; Rumbaut RE; Lopez JA; Thiagarajan P
Thromb Haemost; 2008 Mar; 99(3):552-7. PubMed ID: 18327404
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of platelet activation by peptide analogs of the beta(3)-intracellular domain of platelet integrin alpha(IIb)beta(3) conjugated to the cell-penetrating peptide Tat(48-60).
Dimitriou AA; Stathopoulos P; Mitsios JV; Sakarellos-Daitsiotis M; Goudevenos J; Tsikaris V; Tselepis AD
Platelets; 2009 Dec; 20(8):539-47. PubMed ID: 19863457
[TBL] [Abstract][Full Text] [Related]
14. Two regions of the human platelet F11-receptor (F11R) are critical for platelet aggregation, potentiation and adhesion.
Babinska A; Kedees MH; Athar H; Sobocki T; Sobocka MB; Ahmed T; Ehrlich YH; Hussain MM; Kornecki E
Thromb Haemost; 2002 Apr; 87(4):712-21. PubMed ID: 12008956
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human platelet function by sulfatides.
Devaiah AK; Raife TJ; Barton JA; Olson JD
Blood Coagul Fibrinolysis; 2000 Sep; 11(6):543-50. PubMed ID: 10997794
[TBL] [Abstract][Full Text] [Related]
16. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
[TBL] [Abstract][Full Text] [Related]
17. Functional interplay between platelet activation and endothelial dysfunction in patients with coronary heart disease.
Robinson SD; Harding SA; Cummins P; Din JN; Sarma J; Davidson I; Fox KA; Boon NA; Newby DE
Platelets; 2006 May; 17(3):158-62. PubMed ID: 16702042
[TBL] [Abstract][Full Text] [Related]
18. Interaction of wheat germ agglutinin and concanavalin A with platelets. Stimulation of platelet functional reactions and binding with membrane glycoproteins.
Smirnova IV; Khaspekova SG; Ignatov VV; Mazurov AV
Biochemistry (Mosc); 1998 Jun; 63(6):710-8. PubMed ID: 9668212
[TBL] [Abstract][Full Text] [Related]
19. Platelet activation: signal transduction via membrane receptors.
Clemetson KJ
Thromb Haemost; 1995 Jul; 74(1):111-6. PubMed ID: 8578442
[TBL] [Abstract][Full Text] [Related]
20. The formation of platelet-leukocyte aggregates varies during the menstrual cycle.
Rosin C; Brunner M; Lehr S; Quehenberger P; Panzer S
Platelets; 2006 Feb; 17(1):61-6. PubMed ID: 16308189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
